Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study
Abstract Background Transient donor hydrops (TDH) is defined as donor hydrops developed within days after laser therapy for twin–twin transfusion syndrome (TTTS) followed by resolution later. The purpose of this study was to evaluate the incidence, neonatal outcomes and predisposing factors of post...
Autores principales: | , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
BMC
2019-03-01
|
Colección: | BMC Pregnancy and Childbirth |
Materias: | |
Acceso en línea: | http://link.springer.com/article/10.1186/s12884-019-2236-4 |
_version_ | 1828312038906003456 |
---|---|
author | Yao-Lung Chang An-Shine Chao Shuenn-Dyh Chang Wen-Fang Li Po-Jen Cheng |
author_facet | Yao-Lung Chang An-Shine Chao Shuenn-Dyh Chang Wen-Fang Li Po-Jen Cheng |
author_sort | Yao-Lung Chang |
collection | DOAJ |
description | Abstract Background Transient donor hydrops (TDH) is defined as donor hydrops developed within days after laser therapy for twin–twin transfusion syndrome (TTTS) followed by resolution later. The purpose of this study was to evaluate the incidence, neonatal outcomes and predisposing factors of post laser therapy TDH in severe TTTS. Methods A total of 142 patients with severe TTTS who received laser therapy were included into this study. The pre-operative characteristics and neonatal outcomes were compared between TTTS with and without post laser therapy TDH. All live neonates received cranial ultrasound examination after delivery, mild cerebral injury was defined as exhibiting at least one of the following: intraventricular hemorrhage (IVH) grade I and II, lenticulostriate vasculopathy and subependymal pseudocysts; severe cerebral injury comprised at least one among the following: IVH grade III or grade IV, cystic periventriculoleukomalacia (PVL) grade II or more, porencephalic cysts, and ventricular dilatation. Fetal survival was defined as living more than 30 days after delivery. Results |
first_indexed | 2024-04-13T16:09:22Z |
format | Article |
id | doaj.art-e15d3b1498b849c4b5d54c50523b1612 |
institution | Directory Open Access Journal |
issn | 1471-2393 |
language | English |
last_indexed | 2024-04-13T16:09:22Z |
publishDate | 2019-03-01 |
publisher | BMC |
record_format | Article |
series | BMC Pregnancy and Childbirth |
spelling | doaj.art-e15d3b1498b849c4b5d54c50523b16122022-12-22T02:40:18ZengBMCBMC Pregnancy and Childbirth1471-23932019-03-011911610.1186/s12884-019-2236-4Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control studyYao-Lung Chang0An-Shine Chao1Shuenn-Dyh Chang2Wen-Fang Li3Po-Jen Cheng4Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineAbstract Background Transient donor hydrops (TDH) is defined as donor hydrops developed within days after laser therapy for twin–twin transfusion syndrome (TTTS) followed by resolution later. The purpose of this study was to evaluate the incidence, neonatal outcomes and predisposing factors of post laser therapy TDH in severe TTTS. Methods A total of 142 patients with severe TTTS who received laser therapy were included into this study. The pre-operative characteristics and neonatal outcomes were compared between TTTS with and without post laser therapy TDH. All live neonates received cranial ultrasound examination after delivery, mild cerebral injury was defined as exhibiting at least one of the following: intraventricular hemorrhage (IVH) grade I and II, lenticulostriate vasculopathy and subependymal pseudocysts; severe cerebral injury comprised at least one among the following: IVH grade III or grade IV, cystic periventriculoleukomalacia (PVL) grade II or more, porencephalic cysts, and ventricular dilatation. Fetal survival was defined as living more than 30 days after delivery. Resultshttp://link.springer.com/article/10.1186/s12884-019-2236-4Twin-twin transfusion syndromeDonor hydropsLaser therapyQuintero stage |
spellingShingle | Yao-Lung Chang An-Shine Chao Shuenn-Dyh Chang Wen-Fang Li Po-Jen Cheng Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study BMC Pregnancy and Childbirth Twin-twin transfusion syndrome Donor hydrops Laser therapy Quintero stage |
title | Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study |
title_full | Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study |
title_fullStr | Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study |
title_full_unstemmed | Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study |
title_short | Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study |
title_sort | predisposing factors and neonatal outcomes for twin twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation a case control study |
topic | Twin-twin transfusion syndrome Donor hydrops Laser therapy Quintero stage |
url | http://link.springer.com/article/10.1186/s12884-019-2236-4 |
work_keys_str_mv | AT yaolungchang predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy AT anshinechao predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy AT shuenndyhchang predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy AT wenfangli predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy AT pojencheng predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy |